| Date | Speaker | Title | Time starts | Duration |
| November 2015 | Chris Kosmidis | Isavuconazole: a new antifungal drug | 0’00’00secs | 0’36’40secs |
| Graham Atherton | Patients and carers disucssion | 0’36’40secs | end | |
| Led by Graham Atherton | Entire meeting (alternate version) |
We had to switch off the discussion with patients after Chris & Graham’s introduction ending at 36min 40sec as the group had to proceed privately. The slides discussed give a good deal of the information we talked about so are well worth reading once the talking has stopped.
Resources mentioned:
Share this post
Latest News posts
Do I Have Coronavirus?
March 19, 2020
Seasonal Viral Epidemics & COVID-19
March 18, 2020
Asthma and Covid 19 – research findings
March 17, 2020
Notice for National Aspergillosis Centre Patients
March 13, 2020
Coronavirus (COVID-19) Social distancing introduced
March 2, 2020
9th Advances Against Aspergillosis and Mucormycosis Conference
February 28, 2020
NAC Comms team becomes NAC CARES team
February 27, 2020
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video